Stephens & Co. Reiterates Overweight on Itron, Maintains $130 Price Target

Itron, Inc.

Itron, Inc.

ITRI

0.00

Stephens & Co. analyst Tommy Moll reiterates Itron (NASDAQ: ITRI) with a Overweight and maintains $130 price target.